publication venue for
- FEASIBILITY AND SHORT-TERM OUTCOMES IN LIVER-FIRST APPROACH: A SPANISH SNAPSHOT STUDY (THE RENACI PROJECT). 1676-1684. 2024
- Pronostic Study of Colorectal cancer: Differences between Screen-Detected and Symptom-Diagnosed Patientes 2024
- Store-Operated Calcium Entry in Breast Cancer Cells Is Insensitive to Orai1 and STIM1 N-Linked Glycosylation. 203-220. 2024
- Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling.. 2439-2449. 2023
- Reply to Jue, J.S.; Alameddine, M. Role of PSA Density and MRI in PSA Interpretation. . 2685-2685. 2023
- SURGERY OF COLORECTAL LIVER METASTASES INVOLVING THE INFERIOR VENA CAVA: A SYSTEMATIC REVIEW. 2965-2975. 2023
- Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs: Results from the RIETE Registry 2023
- Validation of a clinicopathological classification for predicting outcomes of pituitary tumours: retrospective cohort study in a pituitary tumour centre of excellence, 2013¿2023. 1-19. 2023
- Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism.. 4127-4134. 2022
- Identification of Leukemia-Associated Immunophenotypes by Databaseguided Flow Cytometry Provides a Highly Sensitive and Reproducible Strategy for the Study of Measurable Residual Disease in Acute Myeloblastic Leukemia. 1-15. 2022
- Lynch-like Syndrome: Potential Mechanisms and Management 2022
- Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors. 1-23. 2022
- The Association between Peptic Ulcer Disease and Gastric Cancer: Results from the Stomach Cancer Pooling (StoP) Project Consortium. 4905-4914. 2022
- EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance.. 1-21. 2021
- Effects of Somatic Methylation in Colonic Polyps on Risk of Developing Metachronous Advanced Colorectal Lesions. 2021
- Family History and Gastric Cancer Risk: A Pooled Investigation in the Stomach Cancer Pooling (STOP) Project Consortium. 3844-3852. 2021
- Metformin Is a Pyridoxal-5¿-phosphate (PLP)-Competitive Inhibitor of SHMT2. 4009-4036. 2021
- Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome. 1-12. 2020
- Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma. 1-20. 2020
- Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines. 1-18. 2020
- Effects of Somatic Methylation in Colonic Polyps on Risk of Developing Metachronous Advanced Colorectal Lesions. 246-260. 2020
- Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization. 3277-3293. 2020
- Mu Opioid Receptor 1 (MOR-1) Expression in Colorectal Cancer and Oncological Long-Term Outcomes: A Five-Year Retrospective Longitudinal Cohort Study 2020
- Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.. 2225-2237. 2020
- How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria? . 1-14. 2019